1. Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor
   Loredana Vesci et al, 2015, Oncotarget CrossRef
2. In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers
   Simone Maschauer et al, 2016, Nuclear Medicine and Biology CrossRef
3. The roles of epigenetic regulation in cholangiocarcinogenesis
   Baiyin Zhong et al, 2023, Biomedicine & Pharmacotherapy CrossRef
4. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells
   MEIYING JI et al, 2015, Oncology Reports CrossRef
5. 4,5-Diaryl imidazoles with hydroxamic acid appendages as anti-hepatoma agents
   Pietro Di Fazio et al, 2015, Investigational New Drugs CrossRef
6. 4-(1-Ethyl-4-anisyl-imidazol-5-yl)-N-hydroxycinnamide – A new pleiotropic HDAC inhibitor targeting cancer cell signalling and cytoskeletal organisation
   Katharina Mahal et al, 2015, Experimental Cell Research CrossRef
7. Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition
   Shengwei Tao et al, 2023, Frontiers in Immunology CrossRef
8. Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell line
   ATSUSHI HIROSE et al, 2013, Oncology Letters CrossRef
9. Regulation of epithelial-mesenchymal transition by protein lysine acetylation
   Fanyun Kong et al, 2022, Cell Communication and Signaling CrossRef
10. Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
    Michaël H. Meel et al, 2020, Clinical Cancer Research CrossRef
11. Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma
    Kwei-Yan Liu et al, 2018, Cancers CrossRef
12. Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review
    Eckhard Klieser et al, 2016, World Journal of Gastrointestinal Pathophysiology CrossRef
13. Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment
    Bernarda Majc et al, 2020, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
14. Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B
    Na Sang et al, 2023, MedComm CrossRef
15. Epigenetics of hepatocellular carcinoma
    Tan Boon Toh et al, 2019, Clinical and Translational Medicine CrossRef
16. Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer
    Pietro Di Fazio et al, 2016, Oncotarget CrossRef
17. Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis
    Mariam Markouli et al, 2021, International Journal of Molecular Sciences CrossRef
18. Emerging Advances in Combinatorial Treatments of Epigenetically Altered Pediatric High-Grade H3K27M Gliomas
    Katarzyna B. Leszczynska et al, 2021, Frontiers in Genetics CrossRef